Oxygen Therapy Market to Reach USD 10.06 Billion by 2033 | North America Leads with 38% Share | Key Players: Philips, ResMed, Invacare

The global oxygen therapy market reached USD 4.69 billion in 2024 and is expected to reach USD 10.06 billion by 2033, growing at a CAGR of 8.9% during the forecast period 2025 to 2033. The market is witnessing strong growth driven by the increasing prevalence of respiratory disorders and the rising demand for home healthcare solutions.

Market growth is fueled by the growing incidence of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory conditions, along with the aging population that is more susceptible to such diseases. The increasing adoption of portable oxygen concentrators and home-based oxygen therapy devices is further accelerating market expansion. Additionally, rising awareness about early diagnosis and long-term respiratory care is contributing to increased demand.

Oxygen therapy plays a critical role in managing patients with respiratory illnesses by ensuring adequate oxygen supply and improving overall quality of life. Technological advancements such as lightweight portable devices, improved battery life, and smart monitoring features are enhancing patient convenience and treatment outcomes. Furthermore, increasing healthcare expenditure, expanding access to respiratory care in emerging markets, and continuous innovation in medical devices are positioning the oxygen therapy market as a key segment within the global healthcare industry.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/oxygen-therapy-market?sai-v

Key Developments

✅ February 2026: Across North America, Europe, and Asia Pacific, rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease and increasing geriatric population significantly boosted demand for oxygen therapy solutions.

✅ January 2026: Advancements in portable oxygen concentrators, smart monitoring systems, and home-based care technologies improved patient mobility, convenience, and treatment adherence.

✅ December 2025: Leading companies such as Philips Healthcare, Invacare Corporation, ResMed, and Drive DeVilbiss Healthcare expanded product portfolios and strengthened global distribution networks.

✅ November 2025: Increasing adoption of home healthcare and long-term oxygen therapy (LTOT) enabled patients to receive continuous treatment outside hospital settings, reducing healthcare costs.

✅ October 2025: Growing integration of oxygen therapy devices with digital health platforms and remote monitoring systems enhanced real-time patient tracking and clinical outcomes.

✅ September 2025: In the United States, strong investments in healthcare infrastructure, respiratory care, and post-pandemic preparedness accelerated market growth.

✅ August 2025: In Japan, increasing focus on aging population healthcare and advanced respiratory care technologies supported the adoption of oxygen therapy solutions.

✅ July 2025: Rising demand for emergency medical services, critical care, and chronic disease management drove continuous innovation and expansion of oxygen therapy systems globally.

Key Players

GE HealthCare | Invacare Corporation | Inogen | Smiths Medical | HERSILL S.L. | Fisher & Paykel Healthcare Limited | Philips Respironics, Inc. | DeVilbiss Healthcare | Tecno-Gaz Industries | Allied Healthcare Products, Inc. | Others

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=oxygen-therapy-market?sai-v

Market Drivers

Rising prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea is significantly driving demand for oxygen therapy solutions.

Growing aging population is increasing susceptibility to respiratory disorders, boosting long-term oxygen therapy adoption.

Increasing preference for home healthcare and portable oxygen devices is accelerating market growth globally.

Rising air pollution levels and smoking-related health conditions are contributing to higher respiratory disease incidence.

Advancements in oxygen concentrators, CPAP devices, and wearable oxygen systems are improving treatment efficiency and patient mobility.

Growing awareness of respiratory health and early treatment is encouraging adoption of oxygen therapy.

Increasing healthcare expenditures and expanding respiratory care services are supporting market expansion.

Industry Developments

Rapid innovation in portable and wearable oxygen concentrators enabling mobility and home-based care.

Strong growth in smart oxygen therapy devices integrated with digital monitoring and remote patient management systems.

Expansion of home oxygen therapy programs reducing hospital stays and healthcare costs.

Increasing adoption of CPAP and high-flow oxygen therapy systems for sleep apnea and critical care.

Strategic mergers, acquisitions, and partnerships among key players to expand product portfolios and global presence.

Growing focus on personalized oxygen therapy based on patient-specific respiratory needs.

Rising investments in advanced oxygen delivery systems and next-generation respiratory care technologies.

Regional Insights

North America 38% share: "Leads the market due to high prevalence of respiratory diseases, advanced healthcare infrastructure, and strong adoption of home oxygen therapy."

Europe 27% share: "Growth driven by increasing respiratory disorders, favorable reimbursement policies, and expanding homecare adoption."

Asia Pacific 25% share: "Fastest-growing region supported by rising pollution levels, large patient population, and improving healthcare infrastructure."

Latin America 6% share: "Emerging growth driven by increasing awareness and improving access to respiratory care."

Middle East & Africa 4% share: "Gradual growth supported by healthcare investments and rising burden of chronic respiratory diseases."

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/oxygen-therapy-market?sai-v

Key Segments

➥ By Product
Oxygen Concentrators: Represent the dominant segment, driven by increasing demand for portable and cost-effective oxygen delivery solutions, especially in home healthcare settings.

Oxygen Cylinders: Represent a significant segment, widely used in emergency and hospital settings for reliable oxygen supply.

Liquid Oxygen Tanks: Represent a notable segment, supported by their high storage capacity and use in long-term oxygen therapy for severe respiratory conditions.

Oxygen Source Equipment: Represents a growing segment, including flowmeters, regulators, and related accessories essential for controlled oxygen delivery.

Others: Include oxygen masks, nasal cannulas, and advanced oxygen delivery systems.

➥ By Application
Chronic Obstructive Pulmonary Disease (COPD): Represents the dominant segment, driven by high global prevalence and long-term oxygen therapy requirements.

Asthma: Represents a significant segment, supported by the need for oxygen support during severe asthma attacks and emergency care.

Obstructive Sleep Apnea: Represents a growing segment, driven by increasing diagnosis rates and demand for respiratory support devices.

Pneumonia: Represents a notable segment, especially in acute care settings requiring supplemental oxygen therapy.

Others: Include respiratory distress syndrome, COVID-19-related complications, and other chronic respiratory diseases.

➥ By End User
Hospitals and Clinics: Represent the dominant segment, driven by high patient volume, emergency care requirements, and availability of advanced medical infrastructure.

Home Healthcare: Represents a rapidly growing segment, supported by increasing preference for home-based care, aging population, and availability of portable oxygen devices.

Others: Include ambulatory care centers and long-term care facilities utilizing oxygen therapy for patient management.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.